Optus Pharmaceutical Co Ltd (131030)

KOSDAQ
Currency in KRW
6,660
+80(+1.22%)
Closed
131030 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 12 days
Fair Value
Day's Range
6,5406,700
52 wk Range
4,85510,430
Key Statistics
Edit
Bid/Ask
6,660.00 / 6,670.00
Prev. Close
6,580
Open
6,540
Day's Range
6,540-6,700
52 wk Range
4,855-10,430
Volume
20.22K
Average Volume (3m)
328.91K
1-Year Change
16.03%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
131030 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Optus Pharmaceutical Co Ltd Company Profile

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea.

Employees
159

Compare 131030 to Peers and Sector

Metrics to compare
131030
Peers
Sector
Relationship
P/E Ratio
11.3x−3.9x−0.5x
PEG Ratio
0.610.010.00
Price/Book
0.8x1.9x2.6x
Price / LTM Sales
1.4x4.0x3.0x
Upside (Analyst Target)
-103.1%56.6%
Fair Value Upside
Unlock18.8%10.1%Unlock

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Optus Pharmaceutical (131030) Stock Price Today?

The Optus Pharmaceutical stock price today is 6,660.00

What Stock Exchange Does Optus Pharmaceutical Trade On?

Optus Pharmaceutical is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Optus Pharmaceutical?

The stock symbol for Optus Pharmaceutical is "131030."

What Is the Optus Pharmaceutical Market Cap?

As of today, Optus Pharmaceutical market cap is 107.58B.

What is Optus Pharmaceutical Earnings Per Share?

The Optus Pharmaceutical EPS is 623.09.

What Is the Next Optus Pharmaceutical Earnings Date?

Optus Pharmaceutical will release its next earnings report on 27 Mar 2025.

From a Technical Analysis Perspective, Is 131030 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.